-
Mashup Score: 7VJHemOnc – The video journal of hematological oncology - 7 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1VJHemOnc – The video journal of hematological oncology - 7 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2VJHemOnc – The video journal of hematological oncology - 7 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2VJHemOnc – The video journal of hematological oncology - 7 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0VJHemOnc – The video journal of hematological oncology - 7 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0VJHemOnc – The video journal of hematological oncology - 7 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0VJHemOnc – The video journal of hematological oncology - 7 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Tanya Siddiqi, MD, City of Hope, Duarte, CA, summarizes outcomes of the Phase I/II TRANSCEND-CLL-004 study (NCT03331198), which is investigating the safety and efficacy of lisocabtagene maraleucel (liso-cel) in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL). This study met its primary endpoint, and Dr Siddiqi talks on the clinical benefit of this CAR-T product in this patient population. To conclude, Dr Siddiqi highlights the curative potential of this therapy and comments on the possibility of using CAR-T cells earlier in the treatment of CLL or in combination with other agents. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0VJHemOnc – The video journal of hematological oncology - 7 month(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Factors to consider when selecting initial therapy in CLL: patient features & preference - 8 month(s) ago
The two main options for initial treatment of chronic lymphocytic leukemia (CLL) are continuous BTK inhibitor therapy, or one-year time-limited therapy. Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, explains factors to consider when selecting initial therapy for patients with CLL, discussing which patient features should be considered and highlighting the role of patient preference. This interview took place at the Eleventh Annual Meeting of the Society of Hematologic Oncology (SOHO 2023) held in Houston, TX. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
How can we optimize frontline therapy in CLL? @mshadman just gave us the 411! Stay tuned 👉https://t.co/O9p0vDBrzw👈 #CLLsm #LEUsm #Leukemia #HemOnc @iwCLL #iwCLL2023 @fredhutch https://t.co/tr4iPWkXCh